HSBC Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
BW
MCM
HSBC Holdings's IHE Position: Q1 2019 in Review
HSBC Holdings sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2019, closing a stake of 5,094 shares — an estimated $239K sold.
HSBC Holdings first reported a position in IHE in Q2 2013 and held it in 23 quarters. The position peaked at $823K in Q1 2014. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2019.
- HSBC Holdings reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
- HSBC Holdings sold 5,094 iShares US Pharmaceuticals ETF shares in Q1 2019, an estimated $239K.
- HSBC Holdings first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 23 quarters.
- HSBC Holdings's iShares US Pharmaceuticals ETF position peaked at $823K in Q1 2014.
- 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2019.
Based on HSBC Holdings's 13F filing for Q1 2019, filed 15 May 2019.